These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2159863

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acid.
    Diver JM, Thornber D, Wise R.
    J Antimicrob Chemother; 1989 Jul; 24(1):89-92. PubMed ID: 2550415
    [No Abstract] [Full Text] [Related]

  • 23. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC.
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE, Hart CA, McLennan AG, Aspinall S.
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [Abstract] [Full Text] [Related]

  • 26. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [Abstract] [Full Text] [Related]

  • 27. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 28. OHIO-1 beta-lactamase resistant to mechanism-based inactivators.
    Bonomo RA, Currie-McCumber C, Shlaes DM.
    FEMS Microbiol Lett; 1992 Apr 01; 71(1):79-82. PubMed ID: 1320587
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M, Moittie D, Philippon A, Descamps P, Veron M.
    J Antimicrob Chemother; 1989 May 01; 23(5):798-800. PubMed ID: 2547748
    [No Abstract] [Full Text] [Related]

  • 33. Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.
    Moosdeen F, Williams JD, Yamabe S.
    Antimicrob Agents Chemother; 1988 Jun 01; 32(6):925-7. PubMed ID: 2843088
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.
    Sabbagh Y, Thériault E, Sanschagrin F, Voyer N, Palzkill T, Levesque RC.
    Antimicrob Agents Chemother; 1998 Sep 01; 42(9):2319-25. PubMed ID: 9736556
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.
    Danelon G, Mascaretti O, Radice M, Power P, Calcagno ML, Mata EG, Gutkind G.
    J Antimicrob Chemother; 1998 Feb 01; 41(2):313-5. PubMed ID: 9533481
    [No Abstract] [Full Text] [Related]

  • 40. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
    Bolivar R, Weaver SS, Bodey GP.
    Diagn Microbiol Infect Dis; 1984 Jun 01; 2(3):255-60. PubMed ID: 6086213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.